Topical Minoxidil 5%

DRUG5 trials

Sponsors

Farid Masoud, Applied Biology, Inc., Shanghai Zhongshan Hospital, Tanta University

Conditions

Androgenetic AlopeciaAndrogenetic Alopecia (AGA)ExosomesFemale Pattern BaldnessMale Pattern Baldness

Early Phase 1

Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia

RecruitingNCT07012486

Shanghai Zhongshan HospitalAndrogenetic Alopecia (AGA)

Start: 2025-06-30End: 2026-12-31Target: 30Updated: 2025-06-10

Phase 3

Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%

CompletedNCT03753113

Farid MasoudAndrogenetic Alopecia

Start: 2018-11-28End: 2019-09-02Updated: 2020-03-16

Clinical Study of Probiotic Treatment for Androgenetic Alopecia

WithdrawnNCT06484881

Applied Biology, Inc.Androgenetic Alopecia, Female Pattern Baldness

Start: 2024-09-15End: 2024-10-10Updated: 2024-10-15

Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss

Not yet recruitingNCT06501924

Applied Biology, Inc.Androgenetic Alopecia, Female Pattern Baldness, Male Pattern Baldness

Start: 2025-01-15End: 2025-12-12Target: 516Updated: 2024-12-19

Unknown Phase

Exosome Injection Versus Topical Minoxidil for Androgenetic Alopecia

CompletedNCT07776015

Tanta UniversityAndrogenetic Alopecia, Exosomes

Start: 2023-04-20End: 2025-12-31Updated: 2026-08-20

Related Papers

Efficacy and safety of a novel herbal solution for the treatment of androgenetic alopecia and comparison with 5% minoxidil: A double‐blind, randomized controlled trial study

Dermatologic Therapy2020-10-2812 citations